Gut microbiota of dogs with cancer receiving anti-EGFR/HER2 immunization reveals potential biomarkers of patient survival
Richard Rosario Rodrigues, Vini Karumuru, Stephanie Nuss, Marina Elliott, Isaiah Shriver, Chih-Min Chao, Ryan C. Berriatua, Hester A. Doyle, Chelsea D. Tripp, Mark J. Mamula, Amiran H. Dzutsev, Andrey Morgun, Natalia Shulzhenko
This study identifies gut microbial taxa associated with survival in dogs receiving anti-EGFR/HER2 immunotherapy, suggesting potential prognostic biomarkers for canine cancer immunotherapy outcomes.
Veterinary oncology. · Dec 12, 2025Peer-reviewedCancer Biology